Literature DB >> 12473679

Structural basis of type VI collagen dimer formation.

Stephen Ball1, Jordi Bella, Cay Kielty, Adrian Shuttleworth.   

Abstract

We have determined the interactive sites required for dimer formation in type VI collagen. Despite the fact that type VI collagen is a heterotrimer composed of alpha1(VI), alpha2(VI), and alpha3(VI) chains, the formation of dimers is determined principally by interactions of the alpha2(VI) chain. Key components of this interaction are the metal ion-dependent adhesion site (MIDAS) motif of the alpha2C2 A-domain and the GER sequence in the helical domain of another alpha2(VI) chain. Replacement of the alpha2(VI) C2 domain with the alpha3(VI) domain abolished dimer formation, whereas alterations in the alpha2(VI) C1 domain did not disrupt dimer formation. When the helical sequences were investigated, replacement of the alpha2(VI) sequence GSPGERGDQ with the alpha3(VI) sequence GEKGERGDV abolished dimer formation. Mutating the Pro-108 to a Lys-108 in this alpha2(VI) sequence did not influence dimer formation and suggests that, unlike the integrin I-domain/triple-helix interaction, hydroxyproline is not required in collagen VI A-domain/helix interaction. These results demonstrate that the alpha2(VI) chain position in the assembled triple-helical molecule is critical for antiparallel dimer formation and identify the interacting collagenous and MIDAS sequences involved. These interactions underpin the subsequent assembly of type VI collagen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473679     DOI: 10.1074/jbc.M209977200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

2.  Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.

Authors:  Rui-Zhu Zhang; Yaqun Zou; Te-Cheng Pan; Dessislava Markova; Andrzej Fertala; Ying Hu; Stefano Squarzoni; Umbertina Conti Reed; Suely K N Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 3.  Microneme proteins in apicomplexans.

Authors:  Vern B Carruthers; Fiona M Tomley
Journal:  Subcell Biochem       Date:  2008

Review 4.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

5.  Collagen VI Muscle Disorders: Mutation Types, Pathogenic Mechanisms and Approaches to Therapy.

Authors:  Shireen R Lamandé
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Autosomal recessive inheritance of classic Bethlem myopathy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Alexandra Columbus; John Shoffner; Diane M Dunn; Robert B Weiss; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2009-11-01       Impact factor: 4.296

7.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

Review 8.  Collagen VI and hyaluronan: the common role in breast cancer.

Authors:  Evgenia Karousou; Maria Luisa D'Angelo; Katerina Kouvidi; Davide Vigetti; Manuela Viola; Dragana Nikitovic; Giancarlo De Luca; Alberto Passi
Journal:  Biomed Res Int       Date:  2014-07-14       Impact factor: 3.411

9.  Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis.

Authors:  Yayoi Izu; Yoichi Ezura; Manuel Koch; David E Birk; Masaki Noda
Journal:  Cell Tissue Res       Date:  2016-01-12       Impact factor: 5.249

10.  Heterogeneity of Collagen VI Microfibrils: STRUCTURAL ANALYSIS OF NON-COLLAGENOUS REGIONS.

Authors:  Tobias Maaß; Christopher P Bayley; Matthias Mörgelin; Sandra Lettmann; Paolo Bonaldo; Mats Paulsson; Clair Baldock; Raimund Wagener
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.